Prodrugs of 4'-substituted nucleoside reverse transcriptase inhibitors
US-2024287124-A1 · Aug 29, 2024 · US
Embrey Mark W is listed as an inventor on 18 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Embrey Mark W |
| Total patents | 18 |
| First publication | Nov 19, 2015 |
| Latest publication | Aug 29, 2024 |
Publications ranked by popularity score, then publication date.
US-2024287124-A1 · Aug 29, 2024 · US
US-12012468-B2 · Jun 18, 2024 · US
US-2024018145-A1 · Jan 18, 2024 · US
US-2023303625-A1 · Sep 28, 2023 · US
US-11530244-B2 · Dec 20, 2022 · US
US-11413292-B2 · Aug 16, 2022 · US
US-2021361662-A1 · Nov 25, 2021 · US
US-2021284694-A1 · Sep 16, 2021 · US
US-10221186-B2 · Mar 5, 2019 · US
US-10150780-B2 · Dec 11, 2018 · US
Latest publications not already listed above.
US-9951079-B2 · Apr 24, 2018 · US
US-2017362252-A1 · Dec 21, 2017 · US
US-2017334924-A1 · Nov 23, 2017 · US
US-2017305923-A1 · Oct 26, 2017 · US
US-9714243-B2 · Jul 25, 2017 · US
US-9707234-B2 · Jul 18, 2017 · US
US-2016317543-A1 · Nov 3, 2016 · US
US-2015329539-A1 · Nov 19, 2015 · US
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Merck Sharp & Dohme | 13 |
| Merck Sharp & Dohme Llc | 6 |
| Ra Pharmaceuticals Inc | 4 |
| Graham Thomas H | 2 |
| Waddell Sherman T | 2 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K45/06 | 13 |
| A61K31/675 | 10 |
| C07D491/20 | 8 |
| A61P31/18 | 7 |
| A61K31/52 | 7 |